Protein arginine N-methyltransferase 4 (PRMT4) contributes to lymphopenia in experimental sepsis.

These findings demonstrate a previously uncharacterised role of a key chromatin modulator in lymphocyte survival that may shed light on devising therapeutic modalities to lessen the severity of septic immunosuppression.